Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hedner

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Thrombosis and Haemostasis|May 25, 1979
International committee communications. Report of the subgroup on fibrinolytic inhibitors, subcommittee on fibrinolysisU Hedner
Scandinavian Journal of Haematology. Supplementum|January 1, 1979
Therapy stimulating the fibrinolytic systemU Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2012
Activated factor VII: my storyU Hedner
Haemostasis|January 1, 1996
Dosing and monitoring NovoSeven treatmentU Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 24, 2009
Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10)U Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
10th anniversary of the haemophilia/haemostasis Novo Nordisk symposiumU Hedner
Current Studies in Hematology and Blood Transfusion|January 1, 1991
Experiences with recombinant factor VIIa in haemophiliacsU Hedner
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1973
Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapyU Hedner
Thrombosis and Haemostasis|December 22, 1999
Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIaU Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 13, 2009
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?U Hedner
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Thrombosis and Haemostasis|May 25, 1979
International committee communications. Report of the subgroup on fibrinolytic inhibitors, subcommittee on fibrinolysisU Hedner
Scandinavian Journal of Haematology. Supplementum|January 1, 1979
Therapy stimulating the fibrinolytic systemU Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2012
Activated factor VII: my storyU Hedner
Haemostasis|January 1, 1996
Dosing and monitoring NovoSeven treatmentU Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 24, 2009
Reply to 'Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors' (Haemophilia 2009; 15: 3-10)U Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
10th anniversary of the haemophilia/haemostasis Novo Nordisk symposiumU Hedner
Current Studies in Hematology and Blood Transfusion|January 1, 1991
Experiences with recombinant factor VIIa in haemophiliacsU Hedner
Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1973
Urinary fibrin-fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapyU Hedner
Thrombosis and Haemostasis|December 22, 1999
Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIaU Hedner
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 13, 2009
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?U Hedner
Pageof 25